Clinical Trials on Hay Fever

Total 1543 results

Sanofi Pasteur, a Sanofi Company

Completed

Passive Enhanced Safety Surveillance of Stamaril® Vaccine in Korea

Yellow Fever

Korea, Republic of
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Immunity After Two Doses of Yellow Fever Vaccine (IATDYFV)

Yellow Fever

Brazil
National Institute of Allergy and Infectious Diseases...

Completed

TY800 Dose Escalation (Typhoid)

Typhoid and Paratyphoid Fevers

United States
BioTech Tools S.A.

Completed

Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis

Hay Fever

Spain, Belgium, Italy
Centre Hospitalier Universitaire Vaudois

Completed

Evaluation of High Speed Laser Doppler Imaging Technology (HSL-DI)

Hay Fever

Switzerland
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers

Dengue | Dengue Hemorrhagic Fever

Mexico
Sanofi Pasteur, a Sanofi Company

Completed

Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America

Dengue | Dengue Hemorrhagic Fever

Brazil
Mahidol University

Completed

Pharmacokinetics and Pharmacodynamics of Ivermectin in Pediatric Dengue Patients (PKIDEN)

Dengue Hemorrhagic Fever

Thailand
Institute of Tropical Medicine, Belgium
London School of Hygiene and Tropical Medicine; Institut National de la Santé... and other collaborators

Completed

Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea (Ebola-Tx)

Hemorrhagic Fever, Ebola

Guinea
Oregon Health and Science University

Recruiting

Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination

Yellow Fever | Immunization; Infection

United States
Centre Hospitalier Universitaire de la Réunion

Active, not recruiting

Factors Associated With Hospitalization for Dengue and Dengue Severity: Hospital-based Cohort Study on Reunion Island (DENGUE-RUN)

Dengue Fever With Warning Signs

France
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus

Dengue Hemorrhagic Fever

United States
Singapore General Hospital
Duke-NUS Graduate Medical School; 60 Degrees Pharmaceuticals LLC

Withdrawn

Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore

Dengue Fever

Singapore
Inviragen Inc.

Completed

Safety and Immunogenicity Study to Assess TDV, a Live Attenuated Tetravalent Vaccine for Prevention of Dengue Fever

Dengue Fever

Colombia
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults

Hemorrhagic Fever, Ebola

United States
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Recruiting

Role of Vitamin D in Prevention of Dengue Haemorrhagic Fever and Dengue Shock Syndrome

Dengue Fever

Bangladesh
London School of Hygiene and Tropical Medicine
University of Sierra Leone; Janssen Vaccines & Prevention B.V.

Active, not recruiting

Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study

Infections | RNA Virus Infections | Virus Diseases | Mononegavirales Infections | Hemorrhagic Fevers, Viral | Hemorrhagic Fever, Ebola | Filoviridae Infections | Physiological Effects of Drugs | Vaccines | Ebola | Immunologic Factors

Sierra Leone
Najit Technologies, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Trial of an Inactivated Yellow Fever Virus Vaccine

Yellow Fever

United States
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination

Yellow Fever

United States, Uganda
AstraZeneca

Completed

Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406)

Rhinitis, Allergic, Seasonal | Hay Fever

Canada
AstraZeneca

Completed

To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)

Rhinitis, Allergic, Seasonal | Hay Fever

United States
AstraZeneca

Completed

Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407)

Rhinitis, Allergic, Seasonal | Hay Fever

Canada
AstraZeneca

Completed

A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)

Rhinitis, Allergic, Seasonal | Hay Fever

Canada
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Study on the Relationship Between Neutrophil-mediated Thrombocytopenia and the Condition and the Course of Disease in Patients With HFRS

Hemorrhagic Fever With Renal Syndrome

China
Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations

Completed

Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana

Lassa Fever

Ghana
French National Agency for Research on AIDS and...

Completed

The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient. (EP46 NOVAA)

HIV Infection | Yellow Fever

France
Nurhasan Agung Prabowo

Recruiting

Lymphocyte Count and High Fluorescent Count (HFLC) Correlate With Liver Disorder in Dengue Fever Patients

Dengue Fever

Indonesia
Kaohsiung Medical University Chung-Ho Memorial...
Centers for Disease Control and Prevention

Unknown

Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection

Dengue Fever

Taiwan
University of Zurich

Active, not recruiting

Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study (ILIT-FNA)

Hypersensitivity | Rhinitis, Allergic, Seasonal | Hay Fever | Rhinoconjunctivitis

Switzerland
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN)

Completed

Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies

Hypersensitivity | Allergy | Rhinitis | Hay Fever

United States
Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations

Completed

Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers

Lassa Fever

United States
BioTech Tools S.A.

Completed

Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis

Hay Fever | Grass Pollen Allergy

Belgium, France, Luxembourg
Evolutec Group

Unknown

Safety and Efficacy Study of rEV131 in Allergic Rhinitis

Hay Fever

United States
University of Oxford
KEMRI-Wellcome Trust Collaborative Research Program; Institut Pasteur; MRC/UVRI... and other collaborators

Completed

Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine (NIFTY)

Yellow Fever

Kenya, Uganda
Centre Hospitalier de Cayenne
European Regional Development Fund

Recruiting

New Tools for Predicting Capillary Leak Shock During Dengue Fever (PrediDengue)

Children | Dengue Fever | Adults

France
U.S. Army Medical Research and Development Command

Recruiting

Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine (RVF)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated (RVF)

Rift Valley Fever

United States
University of Oxford

Completed

Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)

Rift Valley Fever

United Kingdom
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers

Hereditary Periodic Fevers

Belgium, Italy, Japan, Russian Federation, Turkey, Spain, Germany, United Kingdom, France, United States, Ireland, Israel, Canada, Hungary, Netherlands, Switzerland
National Institute of Allergy and Infectious Diseases...

Completed

Rift Valley Fever in Kenya

Rift Valley Fever

Kenya
Karolinska Institutet

Completed

Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.

Allergic Rhinitis | Rhinitis, Allergic, Seasonal | Hay Fever | Pollen Allergy

Sweden
Johnson & Johnson Consumer and Personal Products...
Pfizer

Completed

Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)

Allergic Rhinitis | Rhinitis, Allergic, Seasonal | Hay Fever | SAR
Rijnstate Hospital
Wageningen University; NIZO Food Research; Allergologiepraktijk Arnhem/Radboud... and other collaborators

Completed

Probiotics for Reduction Of Markers In Subjects With Allergy (PROMISA)

Hay Fever | Birch Pollen Allergy

Netherlands
Sri Edupuganti
National Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaborators

Recruiting

Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine

Yellow Fever

United States
AstraZeneca

Completed

To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405)

Rhinitis, Allergic, Perennial | Hay Fever

United States
University of Oxford
MRC/UVRI and LSHTM Uganda Research Unit

Completed

A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults

Rift Valley Fever | RVF

Uganda
U.S. Army Medical Research and Development Command

Completed

Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine (MP-12)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of Rift Valley Fever Vaccine (RVF)

Rift Valley Fever

United States
University Hospital Center of Martinique
Institut National de la Santé Et de la Recherche Médicale, France; Clinique...

Recruiting

Cohort of Patients Infected by an Arbovirus (CARBO)

Fever | Dengue | Chikungunya | Zika Virus

France, French Guiana, Guadeloupe, Martinique, Réunion
National University Hospital, Singapore
Tan Tock Seng Hospital; Ng Teng Fong General Hospital

Completed

Prospective Study for the Evaluation of Dengue Prognostic Biomarkers in Singapore

Dengue Hemorrhagic Fever | Severe Dengue | Dengue Shock Syndrome

Singapore

Clinical Trials on Hay Fever

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations